News | September 30, 2023
Advent International announces the completion of the acquision of Suven Pharma
New Board of Directors and management team at Suven Pharma also appointed
New Board of Directors and management team at Suven Pharma also appointed
40,000 visitors and representatives of more than 80 countries set to visit the show
Dr. Mahdavi will lead Ginkgo's commercial efforts in the growing areas of bio-reagents, cell and gene therapies and new biopharmaceutical modalities.
_256_384.jpg){kind=logo}
Meets the growing need for US-based API solubility and bioavailability enhancement services
Brings 25 years of global operations and supply chain experience to Piramal
Purpose-built bioconjugation facility in Lonza’s Ibex Dedicate Biopark in Visp, Switzerland to support the potential commercial launch of Kodiak's lead product candidate KSI-301 for high-prevalence retinal diseases
Subscribe To Our Newsletter & Stay Updated
